Madrigal Pharmaceuticals, Inc. (MDGL): Free Cash Flow
-$190.02M
Year ended 2025-12-31
-$206.28M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$190.02M | n/m | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | -$457.03M | n/m | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | -$325.71M | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$225.07M | n/m | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | -$184.13M | n/m | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | -$157.90M | n/m | 2023-03-03, From 2020-01-01 |
| 2019-12-31 | -$41.80M | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$25.53M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$22.44M | n/m | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | -$17.61M | n/a | 2019-02-27, From 2016-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$190.02M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$320.03M | n/m |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $171.39M | +258.7% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $347.89M | +59.1% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $105.15M | -33.1% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $246.45M | +1.3% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $156.89M | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $327.58M | +61.1% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $141.78M | -27.7% |
Compare MDGL, IONS, ANIP, HRMY side by side · Screen every company in Pharmaceutical Preparations ↗